So we now have RSV vaccines. What's our next steps?

Expert Rev Respir Med. 2024 Jan-Feb;18(1-2):17-22. doi: 10.1080/17476348.2024.2331764. Epub 2024 Mar 19.

Author

Joseph M Blondeau^{1

2

3}

Affiliations

¹ Division of Clinical Microbiology, Royal University Hospital and Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
² Departments of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
³ Departments of Pathology and Laboratory Medicine and Ophthalmology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

PMID: 38486441
DOI: 10.1080/17476348.2024.2331764

No abstract available

Keywords: Paediatrics; RSV; adults; elderly; respiratory infection; vaccine.

Publication types

Editorial

MeSH terms

Humans
Respiratory Syncytial Virus Infections* / epidemiology
Respiratory Syncytial Virus Infections* / prevention & control
Respiratory Syncytial Virus Vaccines*
Respiratory Syncytial Virus, Human*

Substances

Respiratory Syncytial Virus Vaccines